+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long-term persistence with statin therapy: a nationwide register study in Finland



Long-term persistence with statin therapy: a nationwide register study in Finland



Clinical Therapeutics 30 Pt 2: 2228-2240



Preventive statin therapy is often recommended as lifelong treatment. The aim of this study was to analyze persistence with statin therapy over a decade of use and to identify factors associated with its discontinuation. Persistence with therapy among new users of statins in 1995 was followed up until December 31, 2005, in Finland using the nationwide drug reimbursement register. Cumulative persistence was analyzed using Kaplan-Meier analysis. A Cox regression model was applied to analyze associations of various baseline covariates with discontinuation. We further modeled the association of time-specific covariates by stratifying the duration of therapy in years and using a logistic regression in which those continuing therapy until the end of follow-up (persistent users) formed the reference group. Adherence, defined as the proportion of days covered by statins, stratified by the timing of discontinuation, was computed for the respective groups. Of the 18,072 new statin users, 73.3% (n =13,254) were aged >54 years and 54.8% (n =9908) were men. Of this cohort, 43.9% (n = 7926) were using statins throughout and at the end of the tenth year. Sex was not associated with persistence at any point. In the Cox model, persons aged 45 to 74 years at initiation were more likely to continue statin use than younger or older age groups. Among those who still used statins after the fifth year of observation, the age difference was not observed in the logistic regression model. The use of 1, 2, 3, or > or =4 cardiovascular drugs before the initiation predicted continuation relative to no cardiovascular drug use (hazard ratio for discontinuation significantly <1.00 in all comparisons). Adherence was best (median 93.9%) among the persistent users. The 10-year persistence with statin use in this general population was approximately 44%. Persons aged 45 to 74 years at initiation and those with at least 1 prescription for another cardiovascular medication were the most likely to continue statin therapy up to the fifth year.

(PDF emailed within 0-6 h: $19.90)

Accession: 054169679

Download citation: RISBibTeXText

PMID: 19281917

DOI: 10.1016/j.clinthera.2008.12.003


Related references

Persistence with statin therapy in diabetic and non-diabetic persons: a nation-wide register study in 1995-2005 in Finland. Diabetes Research and Clinical Practice 84(1): E9-E11, 2009

Long-term mortality risk by cause of death in newly diagnosed patients with epilepsy in Finland: a nationwide register-based study. European Journal of Epidemiology 28(12): 981-990, 2014

Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study. Pain 158(2): 252-260, 2017

Long-term use of opioids for non-malignant pain among community-dwelling persons with and without Alzheimer's disease in Finland: a nationwide register-based study. Pain (): -, 2016

Short-term and long-term effects of psychosocial therapy for people after deliberate self-harm: a register-based, nationwide multicentre study using propensity score matching. Lancet. Psychiatry 2(1): 49-58, 2017

From systemic hormone therapy to vaginal estrogen - a nationwide register study in Finland, 2003-2012. Maturitas 78(4): 293-297, 2015

Long-term persistence in use of statin therapy in elderly patients. JAMA (Journal of the American Medical Association) 288(4): 455-461, July 24-31, 2002

Effects of vitamin D supplementation on adherence to and persistence with long-term statin therapy: Secondary analysis from the randomized, double-blind, placebo-controlled ViDA study. Atherosclerosis 273: 59-66, 2018

Long term persistence with statin therapy -- experience in Australia 2006-2010. Australian Family Physician 40(5): 319-322, 2011

Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study. European Heart Journal 37(11): 908-916, 2017

Do immigrants from Turkey, Pakistan and Ex-Yugoslavia with newly diagnosed type 2 diabetes initiate recommended statin therapy to the same extent as Danish-born residents? A nationwide register study. European Journal of Clinical Pharmacology 69(1): 87-95, 2013

Trends in early outpatient drug therapy in pediatric inflammatory bowel disease in Finland: a nationwide register-based study in 1999-2009. Isrn Gastroenterology 2012: 462642, 2012

Long-term use of antipsychotics among community-dwelling persons with Alzheimer׳s disease: A nationwide register-based study. European Neuropsychopharmacology 25(10): 1706-1713, 2016

Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study. Scandinavian Journal of Urology 50(5): 338-345, 2017

Pattern of statin use among 10 cohorts of new users from 1995 to 2004: a register-based nationwide study. American Journal of Managed Care 16(2): 116-122, 2010